CLINICAL_TRIALS
trial_result
· 2017-05-08
Clinical Trial Update: Post-approval Clinical Study of Asfotase Alfa Treatment for Patients With Hypophosphatasia (HPP) in Japan [Phase 4]
Summary
This document reports results from a Phase 4 post-approval clinical study of asfotase alfa in Japanese patients with hypophosphatasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Hypophosphatasia | Phase 4 | Status: COMPLETED | Results posted: 2017-05-08